| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S000711450788634X |
| P698 | PubMed publication ID | 18179727 |
| P50 | author | Kim G. Jackson | Q39962672 |
| Jan Frank | Q42501027 | ||
| P2093 | author name string | Gerald Rimbach | |
| Patricia Huebbe | |||
| Anne-Marie Minihane | |||
| Laia Jofre-Monseny | |||
| Christine Boesch-Saadatmandi | |||
| Inken Stange | |||
| P2860 | cites work | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease | Q22248091 |
| Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease | Q24312335 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| Effect of protein SV-IV on experimental Salmonella enterica serovar Typhimurium infection in mice. | Q28344525 | ||
| The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation | Q34116523 | ||
| Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease | Q34334423 | ||
| Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review | Q34554320 | ||
| ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. | Q35070590 | ||
| Regulation of cell signalling by vitamin E | Q35105487 | ||
| Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease. | Q35769294 | ||
| Physiological factors influencing vitamin E biokinetics | Q36064386 | ||
| C-reactive protein in atherosclerosis: A causal factor? | Q36453512 | ||
| Vitamin E in humans: an explanation of clinical trial failure | Q36604517 | ||
| C-reactive protein: a nontraditional serum marker of cardiovascular risk | Q36705687 | ||
| Gene-environment interaction and its impact on coronary heart disease risk | Q36738515 | ||
| ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation | Q36804822 | ||
| Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression | Q40148295 | ||
| Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages | Q40155000 | ||
| Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding. | Q40748661 | ||
| Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions | Q40942812 | ||
| Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides | Q41172424 | ||
| Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. | Q41191897 | ||
| Isoprostanes: potential markers of oxidant stress in atherothrombotic disease | Q41668888 | ||
| Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study | Q43546731 | ||
| Comparison of a vitamin E-rich diet and supplemental vitamin E on measures of vitamin E status and lipoprotein profile | Q43682250 | ||
| Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study | Q43745376 | ||
| Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. | Q43833271 | ||
| Glutathione peroxidase activity in selenium-deficient rat liver | Q43897516 | ||
| Influence of apolipoprotein E polymorphism on plasma vitamin A and vitamin E levels | Q43959120 | ||
| B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice | Q44212443 | ||
| The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe | Q44236040 | ||
| Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (11210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea | Q44484304 | ||
| The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). | Q45168265 | ||
| Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans | Q46050444 | ||
| Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease | Q46890710 | ||
| Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype | Q48110773 | ||
| Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. | Q48668563 | ||
| Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. | Q48832930 | ||
| Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. | Q52211339 | ||
| Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. | Q52212472 | ||
| HDL is the major source of vitamin E for type II pneumocytes. | Q52976552 | ||
| New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. | Q53631509 | ||
| The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. | Q54632836 | ||
| Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine | Q56879285 | ||
| Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study | Q57337259 | ||
| Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project | Q57995959 | ||
| Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study | Q61560288 | ||
| Alpha-tocopherol: Its inhibition on human platelet aggregation | Q67462958 | ||
| Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
| Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase | Q68355661 | ||
| A spectrophotometric method for determination of catalase activity in small tissue samples | Q70242509 | ||
| Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 | ||
| Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis | Q73500603 | ||
| Immune responsiveness of splenocytes after chronic daily melatonin administration in male Syrian hamsters | Q73626712 | ||
| Enteral vitamin E supplementation inhibits the cytokine response to endotoxin | Q73951347 | ||
| Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice | Q77407922 | ||
| Phytic acid inhibits free radical formation in vitro but does not affect liver oxidant or antioxidant status in growing rats | Q77532054 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 44-53 | |
| P577 | publication date | 2008-01-08 | |
| P1433 | published in | British Journal of Nutrition | Q4970206 |
| P1476 | title | Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice | |
| P478 | volume | 100 |
| Q26741633 | APOE genotype and stress response - a mini review |
| Q35863361 | Apolipoprotein E genotype affects tissue metallothionein levels: studies in targeted gene replacement mice |
| Q42444435 | Effect of apoE genotype and dietary quercetin on blood lipids and TNF-alpha levels in apoE3 and apoE4 targeted gene replacement mice |
Search more.